Tag: Perspective Therapeutics
Perspective Therapeutics, Bristol Myers Squibb partner to evaluate drug combo for skin cancer
Perspective Therapeutics has entered into a clinical collaboration with Bristol Myers Squibb to investigate the safety and tolerability of its alpha-particle therapy VMT01 and...
Medtech companies merge to form Perspective Therapeutics
Coralville-based Viewpoint Molecular Targeting has formally merged with Isoray Inc. out of Richland, Washington to become Perspective Therapeutics.
The company currently trades on the New...